merck & co. news - Search News

Merck Gets China Nod on HPV Shot for Men

Merck says HPV vaccine for men approved by China's drug regulator

U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration, providing a much-needed boost to the company in a key market.

Bloomberg L.P. · 1d

Merck Gets China Nod on HPV Shot for Men Amid Sales Slump

China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the US drug giant after a rush among women to get the shot lost steam.

Business Insider · 1d

Merck’s Gardasil receives expanded approval for males in China

Merck (MRK) announced that the National Medical Products Administration of China approved Gardasil Vaccine for use in males 9-26 years of age

Reuters · 1d

Merck's HPV vaccine gets China approval for men amid declining sales

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a much-needed boost in a key market where demand has been falling among women.

23h

Merck & Co. Inc. stock outperforms competitors despite losses on the day

The stock's fall snapped a two-day winning streak.

WuXi Bio to Sell Vaccine Facility to Merck for $500 Million

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...

2don MSN

WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million

WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...

Merck & Co. Inc. stock underperforms Tuesday when compared to competitors despite daily gains

This was the stock's second consecutive day of gains.

China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

19h

AstraZeneca and Merck drugs set to shake up treatment of liver cancer

Two late-stage studies published Wednesday in The Lancet show that Astra's Imfinzi and Merck's Keytruda delayed the progress ...

Astra, Merck Drugs Set to Shake Up Liver Cancer Treatment

Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients, marking ...

3don MSN

China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 million

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...

Yahoo Finance1d

Merck & Co., Inc. (MRK)

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).

bovnews1d

What’s Fueling Merck & Co Inc (MRK) Stock’s -13.49% Loss Below Its 200-Day SMA?

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $101.02 which represents a slight increase of $1.30 or 1.30% from the prior close of $99.72. The stock opened at $100.13 and touched a ...

24/7 Wall St. on MSN1d

Merck Just Paid Investors: How Much Did They Receive?

Merck & Co. Inc. (NYSE: MRK) is rewarding its shareholders once again with a quarterly dividend of $0.81 per share, payable ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results